Drug intelligence / Profile preview

Modified Xuanxiong Chengqi Decoction

Development stage: Preclinical
Lead developer: Shaoxing Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Modified Xuanxiong Chengqi Decoction is a traditional Chinese medicine (TCM) prescription from the Shao School, currently under investigation for its therapeutic effects in patients with Parkinson's Disease Constipation. It is administered orally in conjunction with conventional Western medications for Parkinson's Disease. Research is focused on understanding its impact on inflammatory mediators and immune mechanisms within the context of the 'Phlegm-Heat Moving Wind' pattern in TCM.

Other names: Shao Lansun's Modified Xuanxiong Chengqi DecoctionModified Xuanxiong Chengqi Tang

Beyond the preview

Go deeper on Modified Xuanxiong Chengqi Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modified Xuanxiong Chengqi Decoction.

Explore the full profile